FluroTech (TSXV:TEST), (“FluroTech” or the “Company”), has successfully completed the development of the test kits for THCa and CBDa. When used with the Company’s flagship quality control and potency optimization testing device, the CompleTest™, accurate, reliable and consistent THCa and CBDa testing results can be achieved onsite within 15 minutes with this user friendly solution.

By having onsite cannabis testing, companies can save the time of shipping samples to the lab, improve the accuracy of labeling and cannabis sorting, pre-validate lab testing results, and optimize potency yield and cannabis curing techniques by testing the cannabis multiple times during the production process.


“FluroTech’s science team has developed a straightforward testing protocol to accurately measure the concentrations of THCa and CBDa. Each test can be done with as little as 0.10 grams of cannabis,” commented Dr. Elmar Prenner, Chief Technology Officer. “I am not aware of any other affordable technology that can achieve the same degree of accuracy without the use of trained lab technicians and relatively expensive lab equipment.”

In preliminary data comparisons for the test for THCa and CBDa, the CompleTest™ results were very close to the results obtained for the same test sample by the current industry standard equipment, High Performance Liquid Chromatography or mass spectrometry. Unlike, the current testing equipment which often requires more data interpretation by scientists which may lead to cross-lab variability, CompleTest™ yielded the same test results on multiple test samples in a row.

The Company expects to obtain independent, third party validation of the THCa and CBDa test kits and the CompleTest™ device in the month of September and allow beta users to provide feedback prior to commercialization in late October.

“This milestone is significant for the Company. I believe that, it advances FluroTech from a research and development company to a position of achieving commercialization. In addition to the now completed heavy metals tests, the test for THCa and CBDa represents the completion of the second of seven prospective revenue streams the Company is actively developing” says CEO, Danny Dalla-Longa.

About CompleTest™

CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of-the-art cannabis testing device, able to provide quick, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with a vested interest in consumer safety to test the quality and safety of their cannabis products and to optimize potency yield.

About FluroTech (TSX-V: TEST)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech‘s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit www.FluroTech.com and watch our video.

Contact Information

FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com

Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com

Prit Singh
IR — Thesis Capital Inc.
905.510.7636
psingh@thesiscapital.ca

Source: www.newsfilecorp.com

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less